$0.652
-0.0591[-8.31%]
At close: May 10
$0.652
0[0.00%]
After Hours: 9:27AM EDT
Monopar Therapeutics
(NASDAQ:MNPR)Monopar Therapeutics Stock (NASDAQ:MNPR), Quotes and News Summary
Monopar Therapeutics Stock (NASDAQ: MNPR) stock price, news, charts, stock research, profile.
| Open | $0.631 |
| Close | $0.672 |
| Volume / Avg. | 130.782K / 5.417M |
| Day Range | 0.630 - 0.750 |
| 52 Wk Range | 0.274 - 1.750 |
| Market Cap | $11.381M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 47 |
| Short Interest | 2.92% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Monopar Therapeutics (MNPR) stock?
You can purchase shares of Monopar Therapeutics (NASDAQ: MNPR) through any online brokerage.
Who are Monopar Therapeutics's (MNPR) competitors?
Other companies in Monopar Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Dominari Holdings (NASDAQ:DOMH) and Coeptis Therapeutics (NASDAQ:COEP).
What is the target price for Monopar Therapeutics (MNPR) stock?
The latest price target for Monopar Therapeutics (NASDAQ: MNPR) was reported by HC Wainwright & Co. on Friday, May 10, 2024. The analyst firm set a price target for 2.00 expecting MNPR to rise to within 12 months (a possible 206.75% upside). 4 analyst firms have reported ratings in the last year.
Current Stock Price for Monopar Therapeutics (MNPR)?
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $0.652 last updated May 10, 2024 at 9:27 AM EDT.
Does Monopar Therapeutics (MNPR) pay a dividend?
There are no upcoming dividends for Monopar Therapeutics.
When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?
Monopar Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Monopar Therapeutics (MNPR) going to split?
There is no upcoming split for Monopar Therapeutics.
What sector and industry does Monopar Therapeutics (MNPR) operate in?
Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.